The mRNA levels of WDR5 and various cell cycle inhibitors were likewise reduced in SLE B cells, suggesting that impaired upregulation of KDM4A and KDM4C may result in enhanced proliferation of SLE B cells upon activation. The gene discussed is KDM4A; the disease is systemic lupus erythematosus.